CytoMed Therapeutics (GDTC)
CytoMed Therapeutics (GDTC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- GDTC last traded at $0.77 on 2026-11-19, -6.87% for the session.
- CytoMed Therapeutics: market cap $9.15M.
- Over the past year GDTC returned -60.56%, with a year-to-date return of -42.10%.